MedPath

Efficacy and safety of preterm formula supplemented with energy substrates for the nutrition of infants of very low birth weight

Completed
Conditions
Very low birth weight
Pregnancy and Childbirth
Disorders related to short gestation and low birth weight, not elsewhere classified
Registration Number
ISRCTN61070850
Lead Sponsor
ational Institute of Paediatrics (Instituto Nacional de Pediatria) (Mexico)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
63
Inclusion Criteria

1. Both male and female infants, aged less than 28 days
2. Hospitalised in the Intensive Care Unit (ICU) or Neonatal Intermediate Care Unit (NICU)
3. Weight less than 1500 g at birth
4. Fed exclusively via enteral route
5. Haemodynamic stability (arterio-venous 3 - 5)
6. Have not received prior formulas with added energy substrates
7. Signed informed consent by parents or guardians

Exclusion Criteria

1. Patients suffering from inborn errors of metabolism in any variant or a disease in itself a negative influence on growth (congenital heart disease, kidney failure, genetic diseases)
2. Post-operative state greater than 72 hours

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Number of days required to reach 1800 g in weight<br>2. Type of treatment administered<br>3. Weight<br>4. Height<br>5. Cephalic perimeter<br>6. Mid-arm circumference<br><br>Measured at 21 days.
Secondary Outcome Measures
NameTimeMethod
1. Biochemical parameters: serum albumin, prealbumin, total protein, creatinine, blood-urea nitrogen (BUN), nitrogen balance<br>2. Security settings: abdominal perimeter, vomiting, stool consistency, temperature, blood in stools, serum glucose, calcium, phosphorus, magnesium, triglycerides<br><br>Measured at 21 days.
© Copyright 2025. All Rights Reserved by MedPath